Evidence map›Paper›PMID 20034955›Full record

ArticleNucleic acids research2010

The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization.

David C F Sealey, Le Zheng, Michael A S Taboski, Jennifer Cruickshank, Mitsuhiko Ikura, Lea A Harrington

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. BioMed research international · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

David C F SealeyDepartment of Medical Biophysics, University of Toronto, Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2C1, Canada.
Le Zheng
Michael A S Taboski
Jennifer Cruickshank
Mitsuhiko Ikura
Lea A Harrington
Ontario Institute for Cancer Research · CAUniversity Health Network · CA

Funding

AGING, DISEASE, AND DRUGS ON DIGITALIS SENSITIVITYR01AG002398 · NIA · MICHIGAN STATE UNIVERSITY · PI BRODY, THEODORE M. · 1985 to 1988
–
CIHRMedical Research Council G0800081NIA NIH HHS AG02398Wellcome Trust WT84637
6 · The paper itself

Abstract

Telomerase defers the onset of telomere damage-induced signaling and cellular senescence by adding DNA onto chromosome ends. The ability of telomerase to elongate single-stranded telomeric DNA depends on the reverse transcriptase domain of TERT, and also relies on protein:DNA contacts outside the active site. We purified the N-terminus of human TERT (hTEN) from Escherichia coli, and found that it binds DNA with a preference for telomeric sequence of a certain length and register. hTEN interacted with the C-terminus of hTERT in trans to reconstitute enzymatic activity in vitro. Mutational analysis of hTEN revealed that amino acids Y18 and Q169 were required for telomerase activity in vitro, but not for the interaction with telomere DNA or the C-terminus. These mutants did not reconstitute telomerase activity in cells, maintain telomere length, or extend cellular lifespan. In addition, we found that T116/T117/S118, while dispensable in vitro, were required for cellular immortalization. Thus, the interactions of hTEN with telomere DNA and the C-terminus of hTERT are functionally separable from the role of hTEN in telomere elongation activity in vitro and in vivo, suggesting other roles for the protein and nucleic acid interactions of hTEN within, and possibly outside, the telomerase catalytic core.

Indexed as

Cell LineCell Line, TransformedCell ProliferationDNADNA-Binding ProteinsEscherichia coliHumansMutationRecombinant Fusion ProteinsTelomeraseTelomereDNADNA-Binding ProteinsRecombinant Fusion ProteinsTelomeraseTERT protein, human

Identifiers

PMID20034955
PMCPMC2847226
OpenAlexW2142087742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.